Stéphane Ramin‐Mangata

Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor)

Aurélie Thedrez, Dirk Blom, Stéphane Ramin‐Mangata et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2017 · 106 citations · Full text

Life Sciences, Genetics, Pharmacology +17

Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk

Benoît J. Arsenault, Francine Petrides, Fatiha Tabet et al. · Journal of clinical lipidology · 2017 · 62 citations · Full text

Life Sciences, Biochemistry, Endocrinology +16

PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate

Mikaël Croyal, Thi-Thu-Trang Tran, Rose Hélène Blanchard et al. · Clinical Science · 2018 · 49 citations

Life Sciences, Immunology, Pharmacology +17

Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?

Mikaël Croyal, Zied Kaabia, Luis León et al. · Diabetes & Metabolism · 2017 · 47 citations

Medicine, Pharmacology, Pharmacotherapy +15

Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study

Valentin Blanchard, Stéphane Ramin‐Mangata, Stéphanie Billon‐Crossouard et al. · Journal of Lipid Research · 2018 · 42 citations · Full text

Life Sciences, Biochemistry, Biochemical Genetics +10